Cns Pharmaceuticals (BE5.F) Q4 2024 Earnings

Nov 14Confirmed
Q4 2024
-11.87
-9.5
-7.12
-4.75

Details

Expected EPS
-4.7482999999999995
Actual EPS
-11.87075
Surprise EPS
-7.12
Surprise Percent
-150%

Description

⁨Cns Pharmaceuticals⁩ (⁦BE5.F⁩) has reported earnings of ⁦-11.87075⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts